Please login to the form below

Not currently logged in
Email:
Password:

Agios Pharma

This page shows the latest Agios Pharma news and features for those working in and with pharma, biotech and healthcare.

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Celgene and Agios Pharma have claimed FDA approval for Idhifa, a new drug that is targeted at patients with a specific genetic mutation. ... That kicked off in 2010 with a $130m upfront payment from Celgene to Agios.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Chris Bowden joins Agios Chris Bowden joins Agios

    Chris Bowden joins Agios. He is former VP, product development oncology at Genentech. ... Agios Pharma has named former Genentech VP Chris Bowden as chief medical officer.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics